Our Locations
Helsinn is headquartered in Lugano, Switzerland. The company has a global presence with a 360° approach of quality, state-of-the-art R&D and world-class production facilities in Biasca, Switzerland and Dublin, Ireland and a growing presence in the United States and China. 3B Future Health Fund (formerly known as Helsinn Investment Fund) created to enhance the future of healthcare by providing funding and strategic support to innovative companies.
Lugano, Switzerland
Our Group’s headquarters in Lugano oversees all central functions: corporate management, business development, R&D, manufacturing and CMC, medical affairs, pharmacovigilance, legal, compliance and quality, finance and administration, commercial operations.
Via Pian Scairolo 9 -6912 Pazzallo-Lugano
Helsinn Healthcare SA
Helsinn Group’s Headquarters
Via Pian Scairolo 9
6912 Pazzallo-Lugano
Tel: +41 91 985 21 21
Fax: +41 91 993 21 22
Biasca, Switzerland
Our GMP manufacturing site in Switzerland develops and manufactures Active Pharmaceutical Ingredients (APIs), High Potency Active Pharmaceutical Ingredients (HPAPIs) and Anticancer Compounds for our products and for third parties.
Via Industria 24, 6710 Biasca, Switzerland
Helsinn Advanced Synthesis S.A.
Via Industria 24
6710 Biasca
Tel: +41 91 873 94 00
Fax: +41 91 873 01 11
Dublin, Ireland
At our GMP facilities in Dublin, we develop and manufacture our finished dosage products and coordinate the Group supply chain platform.
Damastown Mulhuddart – Dublin 15
Helsinn Birex Pharmaceuticals Ltd.
Damastown Mulhuddart
Dublin 15, Ireland D15 X925
Tel: +353 1 822 54 04
Fax: +353 1 822 54 10
Iselin, NJ, United States
Integrated pharmaceutical subsidiary, with commercial, medical, development and regulatory functions. Promoting and co-promoting in the U.S.
170 Wood Avenue South, 5th Floor - Iselin, NJ 08830
Helsinn Therapeutics (U.S.), Inc.
170 Wood Avenue South, 5th Floor
Iselin, NJ 08830
Tel: +1 732 603 2800
Fax: +1 732 744 1088
Principality of Monaco, Monaco
3B FUTURE Health Ventures s.a.r.l.
3B FUTURE Health Ventures, formerly known as Helsinn International Services, is the strategic and scientific advisor to 3B FUTURE Health Fund.
3B FUTURE HEALTH VENTURES SARL, 7-9, AV. DE GRANDE-BRETAGNE, LE MONTAIGNE – BLOC C, 98000 MONACO, PRINCIPAUTE DE MONACO
3B FUTURE Health Ventures s.a.r.l.
7-9 Avenue de Grande Bretagne
Le Montaigne – Bloc C
98000 Monaco
Principality of Monaco
+377 97 98 30 80
Beijing, China
Coordinates clinical and regulatory activities for new product registration with CFDA, collaborates with and provides support to our partners.
Fortune Financial Center, No. 5, Dong San Huan Zhong Road, Chaoyang District Beijing 100020
Helsinn Pharmaceuticals (Beijing) Co., Ltd.
Level 26, Fortune Financial Center, No. 5
Dong San Huan Zhong Road
Chaoyang District
Beijing 100020
北京市朝阳区东三环中路5号财富金融中心26层
Tel: +86 10 5775 0390
Shanghai, China
Helsinn China coordinates clinical and regulatory activities for the product registration with NMPA, collaborates with our partners on the commercialization of our products, including co-detailing in Shanghai.
Xin Zha Lu, Jingan Qu, Shanghai Shi, China
Helsinn Pharmaceuticals (Beijing) Co., Ltd. Shanghai branch
One Museum Place, 40th Floor
No. 669 XinZha Road
Jing’An District
Shanghai
上海市静安区新闸路669号博华广场40层
Tel: +86 21 6103 7136